CEO and Co-Founder, Tamr
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Partner at New Enterprise Associates
Co-Founder and CEO, Wetpaint
San Diego Venture Group has organized a panel discussion on the future of investing in biotech startups. Pockets of resources are emerging around the world in an effort to fundamentally change drug development and healthcare strategy. The panel, moderated by Venrock partner William Rastetter, includes Frazier Healthcare partner Bob Moore, Lilly Ventures Managing Director Edward Torres, and Latterell Venture Partner’s Ken Widder. Online registration is here.